Zobrazeno 1 - 10
of 1 616
pro vyhledávání: '"Mar BG"'
Autor:
Varkaris A; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Pazolli E; Relay Therapeutics, Inc., Cambridge, Massachusetts., Gunaydin H; Relay Therapeutics, Inc., Cambridge, Massachusetts., Wang Q; D. E. Shaw Research, New York, New York., Pierce L; Relay Therapeutics, Inc., Cambridge, Massachusetts., Boezio AA; Relay Therapeutics, Inc., Cambridge, Massachusetts., Bulku A; Relay Therapeutics, Inc., Cambridge, Massachusetts., DiPietro L; Relay Therapeutics, Inc., Cambridge, Massachusetts., Fridrich C; Relay Therapeutics, Inc., Cambridge, Massachusetts., Frost A; Altos Labs, Institute of Science, San Francisco, California.; Department of Biochemistry and Biophysics, University of California San Francisco, San Francisco, California.; California Institute of Quantitative Biosciences (QB3), University of California San Francisco, San Francisco, California., Giordanetto F; D. E. Shaw Research, New York, New York., Hamilton EP; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee., Harris K; MGH/Mass General Cancer Center at Danvers, Danvers, Massachusetts., Holliday M; Relay Therapeutics, Inc., Cambridge, Massachusetts., Hunter TL; Relay Therapeutics, Inc., Cambridge, Massachusetts., Iskandar A; Relay Therapeutics, Inc., Cambridge, Massachusetts., Ji Y; Hematology/Oncology, Exeter Hospital, Exeter, New Hampshire., Larivée A; Paraza Pharma, Inc. Montreal, Canada., LaRochelle JR; Relay Therapeutics, Inc., Cambridge, Massachusetts., Lescarbeau A; Relay Therapeutics, Inc., Cambridge, Massachusetts., Llambi F; Relay Therapeutics, Inc., Cambridge, Massachusetts., Lormil B; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Mader MM; Relay Therapeutics, Inc., Cambridge, Massachusetts., Mar BG; Relay Therapeutics, Inc., Cambridge, Massachusetts., Martin I; Relay Therapeutics, Inc., Cambridge, Massachusetts., McLean TH; Relay Therapeutics, Inc., Cambridge, Massachusetts., Michelsen K; Relay Therapeutics, Inc., Cambridge, Massachusetts., Pechersky Y; D. E. Shaw Research, New York, New York., Puente-Poushnejad E; Relay Therapeutics, Inc., Cambridge, Massachusetts., Raynor K; Relay Therapeutics, Inc., Cambridge, Massachusetts., Rogala D; Relay Therapeutics, Inc., Cambridge, Massachusetts., Samadani R; Relay Therapeutics, Inc., Cambridge, Massachusetts., Schram AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Shortsleeves K; Relay Therapeutics, Inc., Cambridge, Massachusetts., Swaminathan S; Relay Therapeutics, Inc., Cambridge, Massachusetts., Tajmir S; MGH Radiology, Harvard Medical School, Boston, Massachusetts., Tan G; Relay Therapeutics, Inc., Cambridge, Massachusetts., Tang Y; Relay Therapeutics, Inc., Cambridge, Massachusetts., Valverde R; Relay Therapeutics, Inc., Cambridge, Massachusetts., Wehrenberg B; Relay Therapeutics, Inc., Cambridge, Massachusetts., Wilbur J; Relay Therapeutics, Inc., Cambridge, Massachusetts., Williams BR; Relay Therapeutics, Inc., Cambridge, Massachusetts., Zeng H; Relay Therapeutics, Inc., Cambridge, Massachusetts., Zhang H; Relay Therapeutics, Inc., Cambridge, Massachusetts., Walters WP; Mass General Cancer Center and Department of Medicine, Harvard Medical School, Boston, Massachusetts., Wolf BB; Relay Therapeutics, Inc., Cambridge, Massachusetts., Shaw DE; D. E. Shaw Research, New York, New York.; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, New York., Bergstrom DA; Relay Therapeutics, Inc., Cambridge, Massachusetts., Watters J; Relay Therapeutics, Inc., Cambridge, Massachusetts., Fraser JS; California Institute of Quantitative Biosciences (QB3), University of California San Francisco, San Francisco, California.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California., Fortin PD; Relay Therapeutics, Inc., Cambridge, Massachusetts., Kipp DR; Relay Therapeutics, Inc., Cambridge, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2024 Feb 08; Vol. 14 (2), pp. 240-257.
Autor:
Paolino J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Dimitrov B; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Apsel Winger B; Department of Pediatrics, Division of Hematology/Oncology, Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Sandoval-Perez A; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Rangarajan AV; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Ocasio-Martinez N; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tsai HK; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Li Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Robichaud AL; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Khalid D; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Hatton C; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gillani R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Polonen P; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Dilig A; Integrated Oncology, Shelton, Connecticut., Gotti G; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Kavanagh J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Adhav AA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gow S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Tsai J; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Li Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Bledsoe J; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Tasian SK; Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, and Department of Pediatrics and Abramson Cancer Center at the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA., Cooper SL; Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland., Cooper TM; Seattle Children's Hospital, Cancer and Blood Disorders Center, Seattle, Washington., Hijiya N; Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Columbia University Irving Medical Center, New York, New York., Sulis ML; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Shukla NN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Magee JA; Division of Pediatric Hematology/Oncology, Washington University/St. Louis Children's Hospital, St. Louis, Missouri., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Burke MJ; Medical College of Wisconsin, Children's Hospital of Wisconsin, Milwaukee, Wisconsin., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Mar BG; Blueprint Medicines, Cambridge, Massachusetts., Jacobson MP; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California., Harris MH; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Stegmaier K; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard University, Cambridge, Massachusetts., Place AE; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts., Pikman Y; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Nov 14; Vol. 29 (22), pp. 4613-4626.
Autor:
Gotlib J; Division of Hematology, Stanford Cancer Institute/Stanford University School of Medicine, Stanford, CA, USA. jason.gotlib@stanford.edu., Reiter A; Department of Hematology and Oncology, University Hospital Mannheim, Heidelberg University, Mannheim, Germany., Radia DH; Guy's & St Thomas' NHS Foundation Trust, London, UK., Deininger MW; Versiti Blood Research Institute and Division Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., George TI; ARUP Laboratories, University of Utah, Salt Lake City, UT, USA., Panse J; Department of Oncology, Hematology, Hemostaseology and Stem Cell Transplantation, University Hospital RWTH Aachen, Aachen, Germany., Vannucchi AM; Center for Research and Innovation of Myeloproliferative Neoplasms - CRIMM, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy., Platzbecker U; Leipzig University, Leipzig, Germany., Alvarez-Twose I; Institute of Mastocytosis Studies of Castilla-La Mancha, Spanish Reference Center of Mastocytosis, Toledo, Spain., Mital A; Department of Hematology and Transplantology, Medical University of Gdansk, Gdansk, Poland., Hermine O; Department of Hematology, CEREMAST, Necker-Enfants Malades Hospital, APHP, and Imagine Institute, INSERM U1163, Paris University, Paris, France., Dybedal I; Department of Hematology, Oslo University Hospital, Oslo, Norway., Hexner EO; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Hicks LK; Division of Hematology/Oncology, St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada., Span L; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Mesa R; Mays Cancer Center at UT Health San Antonio MD Anderson, San Antonio, TX, USA., Bose P; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pettit KM; University of Michigan, Ann Arbor, MI, USA., Heaney ML; Columbia University Medical Center, New York, NY, USA., Oh ST; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO, USA., Sen J; Blueprint Medicines Corporation, Cambridge, MA, USA., Lin HM; Blueprint Medicines Corporation, Cambridge, MA, USA., Mar BG; Blueprint Medicines Corporation, Cambridge, MA, USA., DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
Nature medicine [Nat Med] 2021 Dec; Vol. 27 (12), pp. 2192-2199. Date of Electronic Publication: 2021 Dec 06.
Autor:
DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. daniel_deangelo@dfci.harvard.edu., Radia DH; Guy's & St Thomas' NHS Foundation Trust, London, UK., George TI; ARUP Laboratories, University of Utah, Salt Lake City, UT, USA., Robinson WA; University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Quiery AT; University of Michigan, Ann Arbor, MI, USA., Drummond MW; Beatson Cancer Centre, Glasgow, UK., Bose P; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hexner EO; Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA., Winton EF; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA, USA., Horny HP; Institute of Pathology, Ludwig-Maximilians University, Munich, Germany., Tugnait M; Blueprint Medicines Corporation, Cambridge, MA, USA., Schmidt-Kittler O; Blueprint Medicines Corporation, Cambridge, MA, USA., Evans EK; Blueprint Medicines Corporation, Cambridge, MA, USA., Lin HM; Blueprint Medicines Corporation, Cambridge, MA, USA., Mar BG; Blueprint Medicines Corporation, Cambridge, MA, USA., Verstovsek S; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Deininger MW; Versiti Blood Research Institute and Division Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA., Gotlib J; Stanford University School of Medicine and Stanford Cancer Institute, Stanford, CA, USA.
Publikováno v:
Nature medicine [Nat Med] 2021 Dec; Vol. 27 (12), pp. 2183-2191. Date of Electronic Publication: 2021 Dec 06.
Autor:
Kawashima, Naomi1 (AUTHOR), Kubota, Yasuo1 (AUTHOR), Bravo-Perez, Carlos1,2 (AUTHOR), Guarnera, Luca1,3 (AUTHOR), Williams, Nakisha D.1 (AUTHOR), Durmaz, Arda1 (AUTHOR), Witt, Michaela1 (AUTHOR), Ahmed, Arooj1 (AUTHOR), Gurnari, Carmelo1,3 (AUTHOR), Maciejewski, Jaroslaw P.1 (AUTHOR), Visconte, Valeria1 (AUTHOR) visconv@ccf.org
Publikováno v:
Journal of Hematology & Oncology. 9/27/2024, Vol. 17 Issue 1, p1-6. 6p.
Autor:
Chen, Yuanxiang1 (AUTHOR), Yang, Shiyu1 (AUTHOR), Yu, Tao1 (AUTHOR), Zeng, Tao1 (AUTHOR), Wei, Lan1 (AUTHOR), You, Yiqing1 (AUTHOR), Tang, Jiafeng1 (AUTHOR), Dang, Tingting1 (AUTHOR), Sun, Haoli1 (AUTHOR), Zhang, Yan1 (AUTHOR) yanzhang@cqmu.edu.cn
Publikováno v:
Cancer Cell International. 9/19/2024, Vol. 24 Issue 1, p1-13. 13p.
Publikováno v:
Cancer Biology & Medicine. Sep2024, Vol. 21 Issue 9, p725-730. 6p.
Autor:
Diz-Küçükkaya, Reyhan1 rkucukkaya@hotmail.com, İyigün, Taner2, Albayrak, Özgür3, Eker, Candan4, Günel, Tuba1
Publikováno v:
Turkish Journal of Hematology. Sep2024, Vol. 41 Issue 3, p167-174. 8p.
Autor:
Della Porta MG; Comprehensive Cancer Center, IRCCS Humanitas Clinical and Research Center and Humanitas University, Milan, Italy., Bewersdorf JP; Department of Internal Medicine, Section of Hematology, Yale University and Yale Cancer Center, New Haven, CT, USA., Wang YH; Epigenetics of Haematopoiesis Laboratory, Division of Cancer Sciences, The University of Manchester, Manchester, UK.; Division of Hematology, National Taiwan University Hospital, Taipei, Taiwan., Hasserjian RP; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Publikováno v:
Histopathology [Histopathology] 2024 Oct 25. Date of Electronic Publication: 2024 Oct 25.
Autor:
Puzo CJ; Yale School of Medicine, New Haven, CT, USA., Hager KM; Department of Laboratory Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA., Rinder HM; Department of Laboratory Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA., Weinberg OK; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Siddon AJ; Department of Laboratory Medicine, Yale School of Medicine, 333 Cedar Street, New Haven, CT, 06520, USA. Alexa.siddon@yale.edu.; Department of Pathology, Yale School of Medicine, New Haven, CT, USA. Alexa.siddon@yale.edu.
Publikováno v:
Annals of hematology [Ann Hematol] 2024 Oct 24. Date of Electronic Publication: 2024 Oct 24.